← back to search

Jingxin Fu

Dana-Farber Cancer Institute · US
Area of research
Oncology · Immunology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Estrogen and related hormone effects, Immune Cell Function and Interaction, and interferon and immune responses.
h-index
17
citations
13,625
works
190
NIH funding
primary concept
email

Recent publications

Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancer
Science Immunology 2023cited by 113position: middledoi
Checkpoint blockade-induced CD8+ T cell differentiation in head and neck cancer responders
Journal for ImmunoTherapy of Cancer 2022cited by 49position: middledoi
Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade
Cancer Discovery 2021cited by 276position: middledoi
TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response
Nucleic Acids Research 2021cited by 130position: middledoi
Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation
Blood 2021cited by 42position: middledoi
TIMER2.0 for analysis of tumor-infiltrating immune cells
Nucleic Acids Research 2020cited by 5,623position: middledoi
Large-scale public data reuse to model immunotherapy response and resistance
Genome Medicine 2020cited by 1,129position: firstdoi
Immune receptor repertoires in pediatric and adult acute myeloid leukemia
Genome Medicine 2019cited by 51position: middledoi
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Nature Medicine 2018cited by 5,504position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

X. Shirley Liu · Ministry of Education of the People's Republic of China5 papers (2018–2022)Shengqing Gu · The University of Texas MD Anderson Cancer Center4 papers (2018–2022)Zexian Zeng · Peking University3 papers (2020–2022)Bo Li · Children's Hospital of Philadelphia3 papers (2018–2020)Xihao Hu · North Sichuan Medical University2 papers (2018–2019)Gordon J. Freeman · Harvard University2 papers (2018–2021)Avinash Sahu · University of New Mexico2 papers (2018–2019)Yi Zhang · Harvard University2 papers (2021–2022)Xiaoqing Wang · Luoyang Orthopedic-Traumatological Hospital of Henan Province2 papers (2021–2022)Liye Zhou · Shanxi Medical University2 papers (2021–2022)David Cohen · Dana-Farber Cancer Institute2 papers (2019–2020)Peng Jiang · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2018–2020)Myles Brown · Harvard University2 papers (2018–2021)Wubing Zhang · Stanford University2 papers (2020–2021)Ravindra Uppaluri · Harvard University1 papers (2021–2021)Kathleen B. Yates · Broad Institute1 papers (2021–2021) · 1 papers (2022–2022)Xia Liu · Qingdao University1 papers (2019–2019)Changxin Wan · Hohai University1 papers (2020–2020)Karen Li · Sun Yat-sen University Cancer Center1 papers (2020–2020)